153 related articles for article (PubMed ID: 28938487)
1. Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5.
Farb TB; Adeva M; Beauchamp TJ; Cabrera O; Coates DA; Meredith TD; Droz BA; Efanov A; Ficorilli JV; Gackenheimer SL; Martinez-Grau MA; Molero V; Ruano G; Statnick MA; Suter TM; Syed SK; Toledo MA; Willard FS; Zhou X; Bokvist KB; Barrett DG
Endocrinology; 2017 Nov; 158(11):3859-3873. PubMed ID: 28938487
[TBL] [Abstract][Full Text] [Related]
2. Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner.
Jepsen SL; Albrechtsen NJW; Windeløv JA; Galsgaard KD; Hunt JE; Farb TB; Kissow H; Pedersen J; Deacon CF; Martin RE; Holst JJ
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434183
[TBL] [Abstract][Full Text] [Related]
3. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist.
Strowski MZ; Cashen DE; Birzin ET; Yang L; Singh V; Jacks TM; Nowak KW; Rohrer SP; Patchett AA; Smith RG; Schaeffer JM
Endocrinology; 2006 Oct; 147(10):4664-73. PubMed ID: 16857751
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.
D'Alessio DA; Fujimoto WY; Ensinck JW
Diabetes; 1989 Dec; 38(12):1534-8. PubMed ID: 2573553
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
[TBL] [Abstract][Full Text] [Related]
10. Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.
Sloop KW; Willard FS; Brenner MB; Ficorilli J; Valasek K; Showalter AD; Farb TB; Cao JX; Cox AL; Michael MD; Gutierrez Sanfeliciano SM; Tebbe MJ; Coghlan MJ
Diabetes; 2010 Dec; 59(12):3099-107. PubMed ID: 20823098
[TBL] [Abstract][Full Text] [Related]
11. Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia.
Kawano T; Tanaka K; Chi H; Eguchi S; Yamazaki F; Kitamura S; Kumagai N; Yokoyama M
Anesth Analg; 2012 Jul; 115(1):62-9. PubMed ID: 22504208
[TBL] [Abstract][Full Text] [Related]
12. Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.
Svendsen B; Holst JJ
Diabetologia; 2021 Jan; 64(1):142-151. PubMed ID: 33043402
[TBL] [Abstract][Full Text] [Related]
13. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
[TBL] [Abstract][Full Text] [Related]
14. The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice.
Wang XP; Norman M; Yang J; Liu SH; Magnusson J; DeMayo FJ; Brunicardi FC
J Surg Res; 2005 Nov; 129(1):64-72. PubMed ID: 16026801
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5.
Zhou G; Liu SH; Shahi KM; Wang H; Duan X; Lin X; Feng XH; Li M; Fisher WE; Demayo FJ; Dawson D; Brunicardi FC
Mol Endocrinol; 2012 Jul; 26(7):1225-34. PubMed ID: 22669743
[TBL] [Abstract][Full Text] [Related]
16. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.
Strowski MZ; Kohler M; Chen HY; Trumbauer ME; Li Z; Szalkowski D; Gopal-Truter S; Fisher JK; Schaeffer JM; Blake AD; Zhang BB; Wilkinson HA
Mol Endocrinol; 2003 Jan; 17(1):93-106. PubMed ID: 12511609
[TBL] [Abstract][Full Text] [Related]
18. Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analogues.
Green BD; Gault VA; Mooney MH; Irwin N; Harriott P; Greer B; Bailey CJ; O'Harte FP; Flatt PR
Biol Chem; 2004 Feb; 385(2):169-77. PubMed ID: 15101559
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase-4 inhibitor MK-626 restores insulin secretion through enhancing autophagy in high fat diet-induced mice.
Liu L; Liu J; Yu X
Biochem Biophys Res Commun; 2016 Feb; 470(3):516-520. PubMed ID: 26802468
[TBL] [Abstract][Full Text] [Related]
20. Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice.
Wang XP; Norman MA; Yang J; Cheung A; Moldovan S; Demayo FJ; Brunicardi FC
Surgery; 2004 Sep; 136(3):585-92. PubMed ID: 15349106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
